Astellas Pharma, Inc. (ALPMF)
13.25
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Astellas Pharma Debt to Equity Ratio : 0.3091 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.3091 |
| December 31, 2025 | 0.4114 |
| September 30, 2025 | 0.4593 |
| June 30, 2025 | 0.6003 |
| March 31, 2025 | 0.6193 |
| December 31, 2024 | 0.691 |
| September 30, 2024 | 0.6785 |
| June 30, 2024 | 0.6552 |
| March 31, 2024 | 0.6302 |
| December 31, 2023 | 0.6457 |
| September 30, 2023 | 0.6042 |
| June 30, 2023 | 0.2274 |
| March 31, 2023 | 0.1326 |
| December 31, 2022 | 0.0947 |
| September 30, 2022 | 0.0499 |
| June 30, 2022 | 0.0725 |
| March 31, 2022 | 0.1457 |
| December 31, 2021 | 0.1374 |
| September 30, 2021 | 0.1445 |
| June 30, 2021 | 0.1456 |
| March 31, 2021 | 0.2008 |
| December 31, 2020 | 0.1454 |
| September 30, 2020 | 0.153 |
| June 30, 2020 | 0.1594 |
| March 31, 2020 | 0.3206 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0955 |
| September 30, 2019 | 0.093 |
| June 30, 2019 | 0.1037 |
| March 31, 2019 | 0.001 |
| December 31, 2018 | 0.0409 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0011 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.0013 |
| December 31, 2016 | 0.0067 |
| September 30, 2016 | 0.0007 |
| June 30, 2016 | 0.0007 |
| March 31, 2016 | 0.001 |
| December 31, 2015 | 0.0006 |
| September 30, 2015 | 0.0006 |
| June 30, 2015 | 0.0006 |
| March 31, 2015 | 0.0008 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.1806 |
| Takeda Pharmaceutical Co., Ltd. | 0.628 |
| Eisai Co., Ltd. | 0.207 |
| Chugai Pharmaceutical Co., Ltd. | 0.0092 |
| Santen Pharmaceutical Co., Ltd. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 22.42B |
| Total Liabilities (Quarterly) | 10.91B |
| Shareholders Equity (Quarterly) | 11.51B |
| Current Ratio | 1.167 |
| Net Debt Paydown Yield | 2.08% |